Serve Robotics' Healthcare Push: Another Unproven Growth Avenue

What happened

Serve Robotics closed its acquisition of Diligent Robotics, adding hospital automation (Moxi robots) to its sidewalk delivery business, aiming to generate $200k–$400k annual sales per facility. However, the company's core food-delivery operations still post deep gross losses—$4.38M on just $0.69M revenue in Q3’25—and scaling has only amplified losses. The Diligent deal adds integration burden and stock-based compensation (1.3M RSUs) without near-term profitability visibility. Meanwhile, the existing narrative of a DoorDash-driven utilization step-change remains unvalidated beyond Los Angeles, and customer concentration (91% with Magna/Uber) persists. Until filings show clear gross-margin compression and multi-partner demand, the healthcare pivot is an additional risk, not a catalyst.

Implication

The Diligent acquisition broadens Serve’s addressable market but does not fix the core problem: the sidewalk delivery business loses money on every robot deployed. Until the company demonstrates that scaling reduces cost per supply hour and that hospital contracts generate recurring software revenue with positive margins, the stock remains a speculative bet on future economics. The acquisition also increases cash burn (purchase price with RSUs) and may require further equity raises—diluting existing shareholders. The upcoming pro forma filing (due within 71 days) is critical to assess Diligent’s historical profitability and the expected earnout. Until then, the risk/reward is unfavorable, with a trim-above of $12 and attractive entry at $7.50 per the master report.

Thesis delta

The addition of healthcare automation through Diligent extends the investment case beyond food delivery but does not alter the near-term thesis: scale is still loss-amplifying, and the company must prove unit-economics improvement. If Diligent’s financials show meaningful recurring high-margin revenue, it could accelerate the timeline to positive gross profit, but given the integration and SBC costs, the base case remains that healthcare is a multi-year drag before contribution.